Yamaguchi, Yoji
Kohta, Masaaki
Ishikawa, Kenji
Naito, Yasuo
Yamaguchi, Michio
Ikeuchi, Yusuke
Shose, Hiroyasu
Tanaka, Kazuhiro
Fujita, Atsushi
Sasayama, Takashi
Article History
Received: 1 October 2025
Accepted: 26 February 2026
First Online: 4 March 2026
Declarations
:
: This study was approved by the Yamaguchi Clinic Institutional Review Board (IRB#1-2024) and followed the principles of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. The requirement for individual informed consent was waived by the Institutional Review Board due to the retrospective and anonymized nature of the data. If participants with cognitive impairment had been included, informed consent would have been obtained from their legal guardians or appropriate representatives. Clinical trial number: not applicable.
: Not applicable.
: The authors declare no competing interests.